KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Receivables (2016 - 2025)

Evolent Health has reported Receivables over the past 11 years, most recently at $311.0 million for Q4 2025.

  • Quarterly results put Receivables at $311.0 million for Q4 2025, down 26.12% from a year ago — trailing twelve months through Dec 2025 was $311.0 million (down 26.12% YoY), and the annual figure for FY2025 was $311.0 million, down 26.12%.
  • Receivables for Q4 2025 was $311.0 million at Evolent Health, down from $408.1 million in the prior quarter.
  • Over the last five years, Receivables for EVH hit a ceiling of $472.4 billion in Q4 2023 and a floor of $127.7 million in Q2 2022.
  • Median Receivables over the past 5 years was $335.4 million (2025), compared with a mean of $23.9 billion.
  • Biggest five-year swings in Receivables: surged 175429.54% in 2023 and later crashed 99.91% in 2024.
  • Evolent Health's Receivables stood at $171.5 million in 2021, then skyrocketed by 56.91% to $269.1 million in 2022, then surged by 175429.54% to $472.4 billion in 2023, then crashed by 99.91% to $420.9 million in 2024, then decreased by 26.12% to $311.0 million in 2025.
  • The last three reported values for Receivables were $311.0 million (Q4 2025), $408.1 million (Q3 2025), and $359.8 million (Q2 2025) per Business Quant data.